Possible mechanism underlying the effect of Semax on the formation of indomethacin-induced ulcers in rats

Bull Exp Biol Med. 2002 Jun;133(6):577-9. doi: 10.1023/a:1020285909696.

Abstract

Intraperitoneal injection of Semax (synthetic analogue of ACTH4-7, MEHFPGP) in a dose of 50 mg/kg produced a protective effect on rats with experimental indomethacin-induced ulcers. Experiments on narcotized rats showed that Semax in the studied dose had no effect on basal blood flow in the stomach, but prevented reduction of blood flow induced by indomethacin. The antiulcer effect of Semax is probably related to improvement of blood flow in the gastric wall disturbed by indomethacin.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / analogs & derivatives*
  • Adrenocorticotropic Hormone / pharmacology*
  • Animals
  • Anti-Ulcer Agents / pharmacology*
  • Indomethacin / adverse effects*
  • Male
  • Peptide Fragments / pharmacology*
  • Rats
  • Regional Blood Flow / drug effects
  • Stomach / blood supply*
  • Stomach / drug effects
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / drug therapy
  • Stomach Ulcer / physiopathology*

Substances

  • Anti-Ulcer Agents
  • Peptide Fragments
  • ACTH (4-7), Pro-Gly-Pro-
  • Adrenocorticotropic Hormone
  • Indomethacin